Results

Total Results: 1,070 records

Showing results for "analyze".

41. App-D-Surv-Report-3-Noninvasive-Nonpharma 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
    January 01, 2022 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in surveillance reports for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number …

42. App-D-Surv-Report-1-Noninvasive-Nonpharma 0 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-1-noninvasive-nonpharma_0.xlsx
    January 01, 2021 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number…

43. App-D-Surv-Report-2-Noninvasive-Nonpharma (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-d-surv-report-2-noninvasive-nonpharma.xlsx
    January 01, 2021 - Title Appendix D. Evidence Table Table D-1. Evidence Table Table D-1. Evidence table for new trials included in Surveillance Report 1 for noninvasive nonpharmacological treatment for chronic pain report Author, Year Country Number of Centers and Setting Inclusion/Exclusion Criteria Number…

44. Medical Therapies for Locally Advanced Gastric Adenocarcinoma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol.pdf
    January 01, 2024 - To reduce clinical heterogeneity, we will analyze studies of patients with resectable tumors or who … For other subgroups which may be effect modifiers such as biomarkers and functional status, we will analyze … We will analyze RCTs and NRSIs separately unless there is reason to believe the studies are sufficiently

45. App-G-Surv-Report-1-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …

46. Medical Therapies for Locally Advanced Gastric Adenocarcinoma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amended.pdf
    February 07, 2025 - To reduce clinical heterogeneity, we will analyze studies of patients with resectable tumors or who … For other subgroups which may be effect modifiers such as biomarkers and functional status, we will analyze … We will analyze RCTs and NRSIs separately unless there is reason to believe the studies are sufficiently

47. Quality-Gap-Palliative-Hospice Executive (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/quality-gap-palliative-hospice_executive.pdf
    October 01, 2012 - Evidence-Based Practice Evidence-based Practice Program The Agency for Healthcare Research and Quality (AHRQ), through its Evidence- based Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public- and private-sector organizations in their efforts to imp…

48. Evidence Report on the (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/crohns-disease_research-protocol.pdf
    September 01, 2010 - • To the extent that we can, we will collect and analyze data by various subgroups, including disease … considering for this review. 2) For our population of interest, we have added a statement that we will analyze … We will analyze the data assuming both homogeneous variance and heterogeneous variance.

49. Cer-235-Pharma-Nonpharm-Ptsd-Update-Appendix-G-1 (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
    May 29, 2025 - G-1. Additions to ROB Template Table G-2. Additions to risk of bias template Rater Author, Year Selection Bias Domain: Randomization Adequate? Selection Bias Domain: Allocation Concealment Adequate? Selection Bias Domain: Groups Similar at Baseline? Selection Bias Domain: ITT Analysis? Performance Bias Domain: Care P…

50. Colorectal-Cancer-Protocol_130520 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-staging_research-protocol.pdf
    May 20, 2013 - colon cancer for inclusion in the report, when possible (as permitted by the reported data), we will analyze … of the rectal tumor—low, middle, or high—may also affect staging accuracy, so when possible we will analyze … and distal colon cancer may also be distinctly different conditions; so if possible, we will try to analyze … For studies of test performance, we will meta-analyze the data reported by the studies using a bivariate … midas” command.31 In cases in which a bivariate binomial regression model cannot be fit, we will meta- analyze

51. Medical Therapies for Locally Advanced Gastric Adenocarcinoma (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gastric-cancers-protocol-amendment.pdf
    May 02, 2025 - To reduce clinical heterogeneity, we will analyze studies of patients with resectable tumors or who … For other subgroups which may be effect modifiers such as biomarkers and functional status, we will analyze … We will analyze RCTs and NRSIs separately unless there is reason to believe the studies are sufficiently

52. App-G-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …

53. Models of Care That Include Primary Care for Adult Survivors of Childhood Cancer: A Realist Review | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/products/childhood-cancer-survivorship-care/research

54. Disposition of Comments Report for Comparative Effectiveness Review #68 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/nppv-respiratory-failure_disposition-comments.pdf
    July 01, 2012 - The analyses have been revised to analyze these groups separately. … analysis where they combined the data across all patient populations The analyses have been revised to analyze … We have revised KQ3 to analyze 3 separated groups: NPPV used to wean from invasive ventilation, NPPV … We have revised KQ3 to analyze 3 separated groups: NPPV used to wean from invasive ventilation, NPPV

55. Slide 1
    effectivehealthcare.ahrq.gov/sites/default/files/estimation-and-reporting_chapter-3.pptx
    January 01, 2013 - Slide 1 Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ) www.ahrq.gov Estimation and Reporting of Heterogeneity of Treatment Effects in Observational Comparative Effectiveness Research …

56. App-G-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-g-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - RCTs Table G-1. Quality assessments of included randomized controlled trials Author, Year Randomization Adequate Allocation Concealment Adequate Patients and Personnel Masked Outcome Assessors Masked Groups Similar at Baseline Intent-to-Treat Analysis (at Least 95% Analyzed) Attrition <20%; Difference Between Groups …

57. Peritoneal Disorders | Effective Health Care (EHC) Program
    effectivehealthcare.ahrq.gov/health-topics/peritoneal-disorders

58. Using Collaborative Platforms for Communities of Practice (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/grama.pdf
    May 29, 2025 - Using Collaborative Platforms for Communities of Practice INNOVATIONS CONFERENCE -- NATIONAL CANCER INSTITUTE SPEAKER: LAKSHMI GRAMA, SENIOR DIGITAL CONTENT STRATEGIST, NATIONAL CANCER INSTITUTE (NCI) GRAMA: I’m Lakshmi Grama from the Office of Communications and Education at the National …

59. Layout 1 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
    May 01, 2006 - Layout 1 Background Anemia (deficiency of red blood cells) occurs in 13-78 percent of patients undergoing treatment for solid tumors and 30-40 percent of patients treated for lymphoma. Tumor type, treatment regimen, and history of prior cancer therapy influence the risk and severity of anemia. For example, among pa…

60. Cer-265-Radiation-Bone-Disease-Addendum-App (xls file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-265-radiation-bone-disease-addendum-app.xlsx
    May 29, 2025 - Title Addendum Appendix - Evidence Table Table1. Evidence Table Addendum Table 1. Evidence table for a randomized controlled trial evaluating external beam radiation therapy for the palliative treatment of metastatic bone disease identified after submission of final report and summarized in …